Hospital-backed Civica Rx nabs Amgen veteran as CEO and targets 14 drugs to knock off

Civica Rx has support from 120 U.S. hospitals in its effort to fight hospital drug shortages. (shironosov/Getty)

A group of hospitals committed to manufacturing their own drugs to battle shortages and high costs now has a name, more support and a pharma manufacturing veteran to oversee the effort.

First announced in January as Project Rx, today the group said it will be named Civica Rx and that it has support from 120 U.S. hospitals. It has named Martin VanTrieste, former chief quality officer for Amgen as its CEO. VanTrieste, a 35-year pharma vet, signed on to run the operation without pay.